Sagittarius Life Science (3205) — Cash Flow Reinvestment Rate

Latest as of September 2025: 143.42x

Sagittarius Life Science (3205) has a Cash Flow Reinvestment Rate of 143.42x as of September 2025, reinvesting NT$17.93 Million (capex NT$83.00K plus investments NT$17.84 Million) from operating cash flow of NT$125.00K. Check cash flow quality index of Sagittarius Life Science to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

143.42x

(Capex + Investments) / Operating CF

Total Reinvested

NT$17.93 Million

Capex + Investments

Operating Cash Flow

NT$125.00K

TWD

Capital Expenditures

NT$83.00K

TWD

Sagittarius Life Science Cash Flow Reinvestment Rate (2015–2016)

Historical reinvestment intensity for Sagittarius Life Science across 2 annual periods. Explore Sagittarius Life Science (3205) investment intensity to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Sagittarius Life Science (2015–2016)

Year-by-year capital reinvestment analysis for Sagittarius Life Science. For live market cap and broader valuation context, see Sagittarius Life Science market capitalisation.

Year	Reinvestment Rate	Total Reinvested (TWD)	Operating CF	Capex	YoY Change
2016	0.29x	NT$104.28 Million	NT$360.37 Million	NT$19.76 Million	▲ +15.2%
2015	0.25x	NT$59.76 Million	NT$237.94 Million	NT$2.95 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow